These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 25816303

  • 1. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Montella P, Brescia Morra V, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G.
    PLoS One; 2015; 10(3):e0120754. PubMed ID: 25816303
    [Abstract] [Full Text] [Related]

  • 2. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 3. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 4. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 5. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment.
    Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R.
    J Neurol Sci; 2014 Dec 15; 347(1-2):229-34. PubMed ID: 25456460
    [Abstract] [Full Text] [Related]

  • 6. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
    Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, Eikelenboom MI, Scheltens PH, Barkhof F, Polman CH.
    Mult Scler; 2005 Oct 15; 11(5):524-31. PubMed ID: 16193889
    [Abstract] [Full Text] [Related]

  • 7. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U, Bozzali M, Spanò B, Cercignani M, Serra L, Basile B, Mannu R, Caltagirone C, De Luca J.
    Brain Imaging Behav; 2014 Sep 15; 8(3):378-86. PubMed ID: 22584774
    [Abstract] [Full Text] [Related]

  • 8. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2019 Feb 15; 25(2):204-216. PubMed ID: 29173009
    [Abstract] [Full Text] [Related]

  • 9. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E, Petsas N, Tona F, Prosperini L, Raz E, Pace G, Pozzilli C, Pantano P.
    PLoS One; 2013 Feb 15; 8(5):e63250. PubMed ID: 23696802
    [Abstract] [Full Text] [Related]

  • 10. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Feb 15; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.
    Pellicano C, Kane RL, Gallo A, Xiaobai L, Stern SK, Ikonomidou VN, Evangelou IE, Ohayon JM, Ehrmantraut M, Cantor FK, Bagnato F.
    J Neuroimaging; 2013 Jul 15; 23(3):445-52. PubMed ID: 23227967
    [Abstract] [Full Text] [Related]

  • 12. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B, Deloire MS, Bonnet M, Salort-Campana E, Ouallet JC, Petry KG, Dousset V.
    Mult Scler; 2008 Nov 15; 14(9):1242-9. PubMed ID: 18653737
    [Abstract] [Full Text] [Related]

  • 13. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI.
    Louapre C, Govindarajan ST, Giannì C, Madigan N, Nielsen AS, Sloane JA, Kinkel RP, Mainero C.
    Neuroimage Clin; 2016 Nov 15; 12():879-886. PubMed ID: 27872810
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 15. Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.
    Roostaei T, Sadaghiani S, Mashhadi R, Falahatian M, Mohamadi E, Javadian N, Nazeri A, Doosti R, Naser Moghadasi A, Owji M, Hashemi Taheri AP, Shakouri Rad A, Azimi A, Voineskos AN, Nazeri A, Sahraian MA.
    Mult Scler; 2019 Apr 18; 25(4):532-540. PubMed ID: 29485352
    [Abstract] [Full Text] [Related]

  • 16. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M.
    Neurology; 2010 Feb 16; 74(7):545-52. PubMed ID: 20157157
    [Abstract] [Full Text] [Related]

  • 17. Gray matter damage predicts the accumulation of disability 13 years later in MS.
    Filippi M, Preziosa P, Copetti M, Riccitelli G, Horsfield MA, Martinelli V, Comi G, Rocca MA.
    Neurology; 2013 Nov 12; 81(20):1759-67. PubMed ID: 24122185
    [Abstract] [Full Text] [Related]

  • 18. Cognitive functions in multiple sclerosis: impact of gray matter integrity.
    Llufriu S, Martinez-Heras E, Fortea J, Blanco Y, Berenguer J, Gabilondo I, Ibarretxe-Bilbao N, Falcon C, Sepulveda M, Sola-Valls N, Bargallo N, Graus F, Villoslada P, Saiz A.
    Mult Scler; 2014 Apr 12; 20(4):424-32. PubMed ID: 24005025
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal associations between MRI and cognitive changes in very early MS.
    Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2016 Jan 12; 5():47-52. PubMed ID: 26856943
    [Abstract] [Full Text] [Related]

  • 20. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
    Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q, Zhang N, Yu C, Barkhof F, Shi FD.
    Neurology; 2015 Oct 27; 85(17):1491-9. PubMed ID: 26423432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.